Benzimidazole and imadazopyridine carboximidamide compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9951065
SERIAL NO

15153527

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors of Formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD SCIENCES, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bartlett, Mark J Castro Valley, US 18 36
Codelli, Julian Andrew Seattle, US 2 9
Corkey, Britton Kenneth Redwood City, US 23 256
Cosman, Jennifer Leigh Foster City, US 4 9
Elbel, Kristyna South San Francisco, US 6 81
Loyer-Drew, Jennifer Alissa Seattle, US 3 13
Sperandio, David Palo Alto, US 48 374
Van, Veldhuizen Joshua Seattle, US 16 128
Yang, Hai San Mateo, US 200 1278
Yeung, Suet Chung Redmond, US 6 61

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00